HCG share price has declined by 30% in the past three months and 38% since our downgrade in February, 2018 and the recent correction offers another opportunity to take a positive view on the stock.

HCG’s performance was decent with recovery promising. Its Q1FY21 revenues and ebitda declined 28% and 57% YoY, respectively. Lower costs led to ebitda exceeding our estimates by 29%. Recovery trends ...

Bangalore-based Healthcare Global Enterprises Ltd (HCG) has agreed to purchase a majority stake in a cancer-care centre in Kenya in its first overseas acquisition. HCG will buy a 93.66% stake in ...

Hi. I am looking for HCG for injection (Pregnyl, Novarel, Profasi etc) & am finding it impossible to find. Even more impossible to find is bacteriostatic water for injection (not sterile water because ...